Table 2

Study schedule of assessments

Visit no.	Screening	Baseline assessment (T0)	Follow-up 1 (T1)	Follow-up 2 (T2)	Follow-up 3 (T3)
	Screening	1	2	3	4
	On referral to UCLH ASCT MDT	On day of first transplant clinic appointment	Day of transplant	Day of discharge from hospital	Post-transplant follow-up clinic at 3 months
Qualitative interview (~20 patients who decline study)	X
Window of flexibility for timing of visits		±2 days	0±1 day	0±1 day	±5 days
Screening eligibility	X
Informed consent		X
Demographics and clinical history		X
Fatigue: FACT-F		X	X	X	X
QOL: EORTC QLQ C-30-MY20		X	X	X	X
QOL: FACT-BMT		X	X	X	X
Exercise behaviour: IPAQ-SF		X	X	X	X
Exercise Self-efficacy Scale		X	X	X	X
Functional capacity: 6MWT		X	X	X	X
Functional capacity: 30 s STS		X	X	X	X
Functional capacity: handheld dynamometry		X	X	X	X
Resting BP and HR		X	X	X	X
Height and weight		X	X	X	X
Accelerometery (3–7 days)		X	X	X	X
Qualitative interview (20 participants)					X
Health and social care service use: CRSI					X
Blood counts		X	X	X	X
Levels of immune function (blood)		X	X	X	X

ASCT, autologous stem cell transplant; BP, blood pressure; EORTC QLQ C-30-MY20, European Organisation for Research and Treatment of Cancer QOL Questionnaire and myeloma specific module; CRSI, Client Service Receipt Inventory; FACT-BMT, Functional Assessment of Cancer Therapy Bone Marrow Transplantation ; FACT-F, Functional Assessment of Chronic Illness Therapy Fatigue questionnaire; HR, heart rate; IPAQ-SF, International Physical Activity Questionnaire short form; MDT, multidisciplinary team; 6MWT, 6 min walk test; QOL, quality of life; STS, sit to stand; UCLH, University College London Hospitals NHS Foundation Trust.